• Study of Pembrolizumab and Lenvatinib for Patients with Resectable Non-Small-Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria

  • Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark France Germany Italy Portugal +1

  • Study on Ustekinumab and Drug Combination for Patients with Severe, Resistant Inflammatory Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Denmark Italy Poland Spain

  • Study on the Effects and Safety of Camizestrant (AZD9833) Compared to Fulvestrant in Postmenopausal Women with Advanced ER-Positive HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Hungary Italy Poland Portugal +1

  • Study on Flecainide and Ranolazine for Restoring Heart Rhythm in Patients with Recent Atrial Fibrillation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece

  • Study on the Safety and Effects of Regadenoson and Gadobutrol in Heart Imaging for Children with Cardiovascular Conditions

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Greece Italy

  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

  • Study on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy Spain

  • Study on the Effects and Safety of Ladarixin for Adults and Adolescents with Recent Onset Type 1 Diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Italy

powered by